Friday, September 22, 2023
9/22/2023
The State of Maine, Department of Health and Human Services (DHHS), Maine Center for Disease Control and Prevention (Maine CDC), Chronic Disease Prevention and Control Program will implement and evaluate evidence-based strategies and protocols that address modifiable risk factors and improve outcomes for the prevention and control of diabetes and cardiovascular disease. This will be achieved through direct engagement with multiple organizations (i.e., health care organizations, community-based organizations, clinicians, non-clinical health care professionals, payers, employers) representing various populations including Medicaid beneficiaries, employees, and low-income populations. These direct engagement activities will be designed to ensure that the DP18-1815 strategies are successfully implemented, performance measures are tracked, and outcomes are attained. Maine CDC’s approach will require health systems to operationalize, expand, and sustain the use of US CDC recommended evidence-based blood pressure management, cholesterol management, diabetes self-management and external support, and diabetes prevention interventions. Maine CDC expects that the expansion of these evidence-based programs and services will impact the health of the population in Maine by: -decreasing the number of people with uncontrolled diabetes, hypertension, and blood cholesterol; -increasing the number of people identified as having prediabetes; -increasing the number of people with prediabetes who lower their risk for developing type 2 diabetes through weight loss; -increasing engagement in self-management of hypertension, high blood cholesterol, prediabetes, and type 2 diabetes. Primary and secondary prevention services also represent an untapped opportunity for cost savings across all the target populations and organizations outlined in Maine’s proposal for this cooperative agreement. Maine CDC’s goal is to provide a sound demonstration of the economics, business practices, and evidence-based initiatives which represent the future of preventing disease progression, reducing disease burden, eliminating health disparities, and improving the overall population health of the citizens of Maine. Maine CDC is confident in its abilities as well as its capacity to achieve meaningful and measurable impact on reducing disease burden and cost with this US CDC state-level investment over the next five years.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
